Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impairments in endocannabinoid signaling and depressive illness.

× No keyword cloud information.

22 in total

Review 1. Neurobiology of chronic mild stress: parallels to major depression.

Authors: Matthew N Hill; Kim G C Hellemans; Pamela Verma; Boris B Gorzalka; Joanne Weinberg
Journal: Neurosci Biobehav Rev Date: 2012-07-07 Impact factor: 8.989

2. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress.

Authors: Matthew N Hill; Cecilia J Hillard; Bruce S McEwen
Journal: Cereb Cortex Date: 2011-01-24 Impact factor: 5.357

Review 3. Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors: Jacob T Borodovsky; Alan J Budney
Journal: Int Rev Psychiatry Date: 2018-05-29

4. Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.

Authors: Laura Kranaster; Carolin Hoyer; Suna Su Aksay; Jan Malte Bumb; F Markus Leweke; Christoph Janke; Manfred Thiel; Beat Lutz; Laura Bindila; Alexander Sartorius
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-03-24 Impact factor: 5.270

Review 5. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis.

Authors: M N Hill; J G Tasker
Journal: Neuroscience Date: 2011-12-24 Impact factor: 3.590

6. Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression.

Authors: Arpana Agrawal; Elliot C Nelson; Andrew K Littlefield; Kathleen K Bucholz; Louisa Degenhardt; Anjali K Henders; Pamela A F Madden; Nicholas G Martin; Grant W Montgomery; Michele L Pergadia; Kenneth J Sher; Andrew C Heath; Michael T Lynskey
Journal: Arch Gen Psychiatry Date: 2012-07

Impairments in endocannabinoid signaling and depressive illness.

Review 1. Neurobiology of chronic mild stress: parallels to major depression.

2. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress.

Review 3. Cannabis regulatory science: risk-benefit considerations for mental disorders.

4. Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.

Review 5. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis.

6. Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression.

7. Circulating endocannabinoid concentrations and sexual arousal in women.

8. Inhibition of monoamine oxidase activity by cannabinoids.

Review 9. Cannabis controversies: how genetics can inform the study of comorbidity.

10. Endocannabinoids differentially modulate synaptic plasticity in rat hippocampal CA1 pyramidal neurons.